TV News LIES

Friday, Jul 03rd

Last update04:01:53 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Industry Payments To Doctors Are Ingrained, Federal Data Show

Industry payments to doctorsFew days went by last year when New Hampshire nephrologist Ana Stankovic didn't receive a payment...

California governor signs strict school vaccine legislation

Vaccine law, CaliforniaCalifornia Governor Jerry Brown signed a mandatory school vaccination bill into law Tuesday, abolishing the “personal...

Cuba stamps out mother-to-child HIV

Cuba leminates mother to child HIVCuba has successfully eliminated mother-to-child transmission of both HIV and syphilis, the World Health Organization (WHO)...

Medical marijuana arrives next week in Minnesota – but smoking it is banned

Medical marijuanaThere will be no baggies of pot awaiting patients next week, when Minnesota joins 21 other...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!